Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02475213
Title Safety Study of MGA271 in Combination With Pembrolizumab in Refractory Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MacroGenics
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic - AZ Scottsdale Arizona 85259 United States Details
Christiana Care Health Services, Inc. Newark Delaware 19713 United States Details
Mayo Clinic - FL Jacksonville Florida 32224 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Norton Cancer Institute Research Program Louisville Kentucky 40202 United States Details
University of Maryland Greenbaum Cancer Center Baltimore Maryland 21201 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
South Texas Accelerated Research Therapeutics, LLC - Midwest Grand Rapids Michigan 49503 United States Details
Mayo Clinic - MN Rochester Minnesota 55905 United States Details
Nebraska Cancer Specialists Omaha Nebraska 68130 United States Details
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Columbia University Medical Center New York New York 10032 United States Details
Gabrail Cancer Institute Canton Ohio 44718 United States Details
Hospital of the University of Pennsylvania/Abramson Cancer Center Philadelphia Pennsylvania 19104 United States Details
University of Pittsburg Pittsburgh Pennsylvania 15232 United States Details
Rhode Island Hospital Providence Rhode Island 02903 United States Details
Greenville Health System Greenville South Carolina 29605 United States Details
Mary Crowley Cancer Research Center Dallas Texas 75230 United States Details
South Texas Accelerated Research Therapeutics, LLC San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field